Clinical Study
The Soluble Plasminogen Activator Receptor as a Biomarker on Monitoring the Therapy Progress of Pulmonary TB-AFB(+) Patients
Table 3
Result of ANOVA Test.
| No | Width of lesion classification | Test | Sig | Sig 0.05 | Conclusion |
| 1 | Min lession, mod advance, far advance | Anova test | Sig F | 0.901 | Not Significant | 2 | Min lession, mod advance | T-test | Sig t | 0.61 | Not Significant | 3 | Min lession, far advance | T-test | Sig t | 0.792 | Not Significant | 4 | Mod advance, far advance | T-test | Sig t | 0.716 | Not Significant |
|
|